Synopsis of recent research by authors named "Zongli Deng"
Recent research by Zongli Deng primarily focuses on the effects of bioactive compounds like resveratrol and hesperidin on diabetes-related complications, including diabetic encephalopathy and diabetic nephropathy.
Deng’s studies emphasize the modulation of specific signaling pathways, such as PDE4D/PKA and Drp1, demonstrating how these compounds can protect against mitochondrial damage and improve cognitive function in diabetic conditions.
Findings from Deng's investigations highlight potential therapeutic roles for resveratrol and hesperidin in alleviating neurochemical abnormalities and anxiety-like behaviors associated with diabetes, presenting promising avenues for further research and clinical application.
